
Advertise on podcast: Endo in a Bite
Rating
5from
This podcast has
72 episodes
Language
EnglishPublisher
Sumbul Beg, MDExplicit
No
Date created
2025/07/09
Latest episode
2026/11/09
Average duration
9 min.
Release period
8 days
Description
This podcast from EZ Endo Prep delivers concise, high yield endocrinology content to help you study smarter and practice with confidence. Each episode breaks down complex topics into manageable pieces, making it ideal for endocrinology fellows and practicing endocrinologists. Whether you're preparing for boards or staying sharp in clinic, Dr. Sumbul Beg, MD brings exam ready pearls and real world relevance straight to your ears.
Unlock Endo in a Bite podcast Email contact info,
Listeners & Audience details
Email contact information
Direct podcast contact details

Listeners
Audience numbers & engagement insights

Audience details
Podcast Insights

Podcast episodes
Check latest episodes from Endo in a Bite podcast
2026 Consensus Statement on the Use of Diabetes Technology for Management of Adults with Diabetes (Part 9)
2026/11/09
In this episode, we review the 2026 Consensus Statement on the use of diabetes technology for management of adults with diabetes, focusing on connected insulin pens, insulin patches, continuous ketone monitoring, telemedicine, and the future of diabetes technology. Topics include smart pen features, missed insulin doses and glycemic control, the benefits and limitations of insulin patches, continuous ketone monitoring, early detection of ketosis and ketoacidosis, telemedicine requirements, remote patient monitoring, and the expanding role of integrated glucose and ketone monitoring.
2026 Consensus Statement on the Use of Diabetes Technology for Management of Adults with Diabetes (Part 8)
2026/11/02
In this episode, we review the 2026 Consensus Statement on the use of diabetes technology for management of adults with diabetes, focusing on mealtime management with automated insulin delivery. Topics include precise carbohydrate counting, qualitative meal estimation, meal announcement strategies, user initiated bolus behavior, timing of mealtime boluses, carbohydrate entry before meals, injection trials before pump therapy, access to AID, C-peptide based restrictions, and strategies for optimizing AID performance and glycemic outcomes.
2026 Consensus Statement on the Use of Diabetes Technology for Management of Adults with Diabetes (Part 7)
2026/10/26
In this episode, we review the 2026 Consensus Statement on the use of diabetes technology for management of adults with diabetes, focusing on the continuation of insulin pump and automated insulin delivery therapy during hospitalization and procedures. Topics include criteria for continuing conventional pump therapy, requirements for continued AID use, point of care glucose monitoring, transitioning to manual mode, sensor accuracy during illness, perioperative considerations, sensor compression, backup planning, and barriers to inpatient adoption of insulin pumps and AID systems.
2026 Consensus Statement on the Use of Diabetes Technology for Management of Adults with Diabetes (Part 6)
2026/10/19
In this episode, we review the 2026 Consensus Statement on the use of diabetes technology for management of adults with diabetes, focusing on automated insulin delivery beyond standard type 1 diabetes care. Topics include AID use during pregnancy, pregnancy specific glucose targets, evidence from pregnancy trials, differences among AID systems, AID in type 2 diabetes, glycemic outcomes, high insulin requirements, cystic fibrosis related diabetes, pancreatic diabetes, and the current evidence and limitations of AID in these populations.
2026 Consensus Statement on the Use of Diabetes Technology for Management of Adults with Diabetes (Part 5)
2026/10/12
In this episode, we review the 2026 Consensus Statement on the use of diabetes technology for management of adults with diabetes, focusing on automated insulin delivery. Topics include automated insulin delivery systems, the three main components of AID, hybrid closed loop function, meal related insulin dosing, temporary activity settings, standardized AID reports, prescribing and clinician training, manufacturer support, evidence in type 1 diabetes, AID as a standard of care option, use in older adults, functional assessment, patient selection, and requirements for safe and effective AID use.
2026 Consensus Statement on the Use of Diabetes Technology for Management of Adults with Diabetes (Part 4)
2026/10/05
In this episode, we review the 2026 Consensus Statement on the use of diabetes technology for management of adults with diabetes, focusing on continuous glucose monitoring in the inpatient setting. Topics include the regulatory status of inpatient CGM, guideline support for continued personal sensor use during hospitalization, hybrid CGM and point of care glucose monitoring, clinical outcomes, factors that reduce CGM accuracy, medication related interference, CGM use during imaging, surgery, and other procedures, inpatient glucose targets, institutional requirements, and electronic health record integration.
2026 Consensus Statement on the Use of Diabetes Technology for Management of Adults with Diabetes (Part 3)
2026/09/28
In this episode, we review the 2026 Consensus Statement on the use of diabetes technology for management of adults with diabetes, focusing on continuous glucose monitoring during pregnancy and the postpartum period. Topics include pregnancy specific CGM targets, time in range and hypoglycemia thresholds, the role of CGM in type 1, type 2, and gestational diabetes, why glucose management indicator is not validated in pregnancy, evidence for maternal and neonatal outcomes, and CGM management during the postpartum and breastfeeding periods.
2026 Consensus Statement on the Use of Diabetes Technology for Management of Adults with Diabetes (Part 2)
2026/09/21
In this episode, we review the 2026 Consensus Statement on the use of diabetes technology for management of adults with diabetes, focusing on continuous glucose monitoring across key patient populations. Topics include CGM use in insulin treated diabetes, non insulin treated type 2 diabetes, chronic kidney disease, individualized management in CKD, compression lows, the lag between blood and interstitial glucose, and substances that may interfere with CGM accuracy.
2026 Consensus Statement on the Use of Diabetes Technology for Management of Adults with Diabetes (Part 1)
2026/09/14
In this episode, we review the 2026 Consensus Statement on the use of diabetes technology for management of adults with diabetes, focusing on continuous glucose monitoring fundamentals, CGM data quality, time in range targets, and glycemic variability. Topics include CGM components and interstitial glucose measurement, key glucose thresholds, the 5-25-70-4-1 CGM targets, hypoglycemia prioritization, coefficient of variation, time in tight range, glucose management indicator, GMI and laboratory A1C discordance, and individualized glucose targets.
GAD65, IAA, IA-2, And ZnT8: Islet Autoantibodies in Type 1 Diabetes
2026/09/07
In this episode, we review the major islet autoantibodies used in type 1 diabetes, focusing on GAD65 in adults, IAA in young children, IA-2 and progression risk, and ZnT8 for additional diagnostic sensitivity. Topics include antibody testing strategies, presymptomatic screening and staging, single versus multiple autoantibody positivity, type 1 diabetes stages, factors affecting antibody interpretation, and the role of C peptide in evaluating autoimmune diabetes.
The 2026 Consensus Statement on the Algorithm for Management of Adults with Type 2 Diabetes: Selecting Glucose Lowering Therapy
2026/08/31
In this episode, we review the 2026 Consensus Statement algorithm for selecting glucose lowering therapy in adults with type 2 diabetes, focusing on cardiovascular, heart failure, kidney, liver, weight, hypoglycemia, adverse effect, and cost considerations. Topics include medication efficacy, cardiovascular and cardiorenal benefits, weight effects, MASLD and MASH, renal dosing, adverse effects, and individualized treatment selection.
The 2026 Consensus Statement on the Algorithm for Management of Adults with Type 2 Diabetes: Insulin Management (Part 3)
2026/08/24
In this episode, we review the 2026 Consensus Statement algorithm for insulin management in adults with type 2 diabetes, focusing on the transition beyond basal insulin. Topics include recognizing overbasalization, initiating and titrating prandial insulin, basal bolus insulin therapy, hypoglycemia classification and treatment, glucagon prescribing, the role of CGM in identifying glucose patterns, premixed insulin therapy, and practical strategies for optimizing glycemic control while minimizing hypoglycemia.
The 2026 Consensus Statement on the Algorithm for Management of Adults with Type 2 Diabetes: Insulin Management (Part 2)
2026/08/17
In this episode, we review the 2026 Consensus Statement algorithm for insulin management in adults with type 2 diabetes, focusing on basal insulin initiation and titration. Topics include selecting the initial basal insulin dose based on A1C, structured titration strategies, dose reduction for hypoglycemia, titration intervals for different basal insulin preparations, once weekly insulin icodec, recognition of overbasalization using glucose patterns and the BEAM score, and when to consider prandial insulin rather than further basal insulin escalation.
The 2026 Consensus Statement on the Algorithm for Management of Adults with Type 2 Diabetes: Insulin Management (Part 1)
2026/08/10
In this episode, we review the 2026 Consensus Statement algorithm for insulin management in adults with type 2 diabetes. Topics include individualized glycemic targets, the role of continuous glucose monitoring (CGM), key CGM metrics and glycemic variability, recognition of severe hyperglycemia, when to initiate insulin, the role of GLP-1 based therapy before insulin in clinically stable patients, and practical strategies for optimizing insulin therapy while minimizing hypoglycemia.
The 2026 Consensus Statement on the Algorithm for Management of Adults with Type 2 Diabetes: Glucose Centric Management (Episode 10)
2026/08/03
In this episode, we review the 2026 Consensus Statement algorithm for glucose centric management in adults with type 2 diabetes. Topics include identifying patients appropriate for a glucose centric approach, metformin as foundational therapy, individualized medication selection based on weight, hypoglycemia risk, cost and access, early combination therapy, management of severe hyperglycemia, appropriate insulin initiation, avoiding inappropriate incretin combinations, and practical strategies for treatment intensification and reducing therapeutic inertia.
Podcast reviews
Read Endo in a Bite podcast reviews
Flubber2500 2025/08/02
Good stuff
really good review of topics in bite sized pieces.
Yourendodoctors 2025/07/10
Perfectly quick and high yield
Excellent addition to studying for the boards or just general info updates for the busy endo.
Podcast sponsorship advertising
Start advertising on Endo in a Bite relevant audience podcasts
You may also like to advertise on these Podcasts

4.959992000
Legal AF by MeidasTouch
MeidasTouch Network

4.7292862000
The Michael Knowles Show
The Daily Wire

4.930912000
The Quote of the Day Show | Daily Motivational Talks
Sean Croxton

4.7278962000
The Matt Walsh Show
The Daily Wire

4.9248151467
Unashamed with the Robertson Family
Tread Lively

4.897071458
The Graham Allen Show
Graham Allen

4.7106622000
FantasyPros - Fantasy Football Podcast
iHeartPodcasts

4.858251936
Sara Gonzales Unfiltered
Blaze Podcast Network

4.6221762000
Mark Levin Podcast
Cumulus Podcast Network

4.942061993
Chente Ydrach
Chente Ydrach